Related Experiment Video
Updated: May 28, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Drug combinations for HIV: what's new?
Andrew Scourfield1, Laura Waters, Mark Nelson
11st Floor, St Stephen's Centre, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.
Expert Review of Anti-Infective Therapy
|October 28, 2011
Summary
Combined antiretroviral therapy (ART) has transformed HIV into a chronic condition. Individualizing ART strategies is crucial to minimize drug toxicity and manage comorbidities for improved patient outcomes.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Background:
- Combined antiretroviral therapy (ART) has significantly improved HIV/AIDS outcomes, making it a manageable chronic condition with near-normal life expectancy.
- Key considerations in ART selection include short- and long-term drug toxicity, management of comorbidities (cardiovascular, renal, hepatic, bone, CNS), coinfections, and malignancy.
- Treatment failure necessitates switches guided by resistance mutations; novel agents offer future therapeutic potential.
Purpose of the Study:
- To review current evidence for antiretroviral therapy (ART) strategies in ART-naive individuals.
- To discuss the role of individualized therapy in reducing drug-related toxicity.
- To explore the potential of novel agents in future HIV management.
Main Methods:
- Review of current evidence for established and emerging ART regimens.
- Analysis of factors influencing ART selection, including toxicity profiles and comorbidity management.
- Discussion of resistance mutation patterns and their impact on treatment decisions.
Main Results:
- ART has shifted HIV from a fatal to a chronic disease, improving life expectancy.
- Individualized therapy and management of comorbidities are vital for reducing toxicity and optimizing treatment.
- Understanding resistance mutations is critical for effective treatment sequencing.
Conclusions:
- ART has revolutionized HIV care, enabling near-normal life expectancy.
- Personalized ART selection, considering toxicity, comorbidities, and resistance, is paramount.
- Ongoing research into novel agents promises further advancements in HIV management.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...